CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

AARTI PHARMALABS LTD.

NSE : AARTIPHARMBSE : 543748ISIN CODE : INE0LRU01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE676.4544.7 (+7.08 %)
PREV CLOSE () 631.75
OPEN PRICE () 649.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 210274
TODAY'S LOW / HIGH ()636.30 714.25
52 WK LOW / HIGH ()380.65 721
NSE677.4545.1 (+7.13 %)
PREV CLOSE() 632.35
OPEN PRICE () 647.00
BID PRICE (QTY) 677.45 (1026)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5315673
TODAY'S LOW / HIGH() 636.10 715.00
52 WK LOW / HIGH ()399.55 721.7
ChairmanRashesh C Gogri
Managing DirectorNarendra J Salvi
Company SecretaryJeevan Mondkar
Non Executive DirectorRajendra V Gogri
Parimal H Desai
Vice Chairman & Managing DirectorHetal Gogri Gala
Non Executive Independent DirectorBhavesh R Vora
Vinay G Nayak
Vilas G Gaikar
Jeenal Savla
Rupal Vora
Pradeep Thakur
Non Independent & Non Executive DirectorNehal Garewal
Incorporation Year : 22-11 2019

Registered Office :

Address : Plot No. 22/ C/1 & 22/ C/2,1st Phase, G. I. D. C.,Valsad Vapi,
Gujarat-396195 .

Phone : 0260 2400467 / 09909994655

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX78699.07226.59 (0.29%)
NIFTY23813.4063.20 (0.27%)
Dow Jones 43325.8028.77 (0.07%)
Nasdaq 20020.36-10.77 (-0.05%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI